Securing Platform Exclusivity through Patents and Software Confidentiality
First written in FY2023. 3 of 4 entries say "Advanced", first in 2026-03-02. Latest entry: 2026-08-05.
12 other companies' latest entry also says "Advanced".
- 2026-08-05AdvancedEarnings presentation
「2 new patent applications were filed in the first half of 2026.」
The filing of 2 new patent applications during the first half of 2026 was reported, concerning a new analytical technology and the business model for Perfusio. - FY2025AdvancedAnnual report
「A patent was granted in the United States in July 2025, securing rights in the major markets of Japan, Europe and the United States and further reinforcing the exclusivity of our business.」
A platform-related patent was granted in the United States, securing rights in the major markets of Japan, Europe and the United States. - 2026-03-02AdvancedGeneral Meetings of Shareholders
「A U.S. patent became effective in July, securing intellectual property rights in the major markets of Japan, Europe and the United States. At the same time, we made major improvements to the rule-based AI implemented in ibVIS® and upgraded it to aibVIS, which has a broader and more effective range of applications.」
The U.S. patent taking effect advanced the securing of rights in the major markets, while improvements to the platform's AI and its upgrade to aibVIS were also reported. - FY2023First statedAnnual report
「We secure the overall exclusivity of the ibVIS® platform through a dual approach: obtaining patent rights for the “target discovery” and “screening” functions of the ibVIS® platform, and keeping confidential the digital technologies comprising various software developed in-house.」
The company’s intellectual property strategy combines patent protection with confidentiality of its digital technologies to secure exclusivity across the platform.